2007 AUA Annual Meeting Podcast - Day Four

Listen to the Urology Times Radio podcast from Day Four of the 2007 AUA Annual Meeting in Anaheim, California. This podcast includes interviews with highly regarded experts in urological medicine including: Jennifer Anger, MD, discusses age as a predictor of poorer sling surgery outcomes Robert Getzenberg, PhD, presents the latest findings on EPCA-2 as a biomarker for prostate cancerMichael Albo, MD, discusses data comparing the sling and Burch procedures for SUI

Related Videos

Related Content

Advertisement

February 12th 2025

UGN-101 associated with favorable long-term durability in low-grade UTUC

Hannah Clarke

The median duration of response was 47.8 months among patients who achieved an initial complete response.

February 11th 2025

Episode 3 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS

Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.

February 11th 2025

Danish Medicines Agency approves PSMA-PET imaging product for prostate cancer

Hannah Clarke

Illuccix has been previously approved in the US, Australia, Canada, and Europe.

January 29th 2025

Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC

Max Kates, MD Neal Shore, MD, FACS Tom Jayram, MD

Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.

February 10th 2025

Trends in urology: Arpeet Shah, MD, on challenges and opportunities in 2025

Arpeet Shah, MD

Arpeet Shah, MD, highlights the shift toward precision medicine, ongoing work force challenges, the integration of AI, and more.

February 10th 2025

FDA grants 510(k) clearance to AI-powered prostate cancer diagnostic

Hannah Clarke

The software generates heatmaps to help identify prostatic tumors that may have been missed on initial reads.

Related Content

Advertisement

February 12th 2025

UGN-101 associated with favorable long-term durability in low-grade UTUC

Hannah Clarke

The median duration of response was 47.8 months among patients who achieved an initial complete response.

February 11th 2025

Episode 3 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS

Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.

February 11th 2025

Danish Medicines Agency approves PSMA-PET imaging product for prostate cancer

Hannah Clarke

Illuccix has been previously approved in the US, Australia, Canada, and Europe.

January 29th 2025

Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC

Max Kates, MD Neal Shore, MD, FACS Tom Jayram, MD

Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.

February 10th 2025

Trends in urology: Arpeet Shah, MD, on challenges and opportunities in 2025

Arpeet Shah, MD

Arpeet Shah, MD, highlights the shift toward precision medicine, ongoing work force challenges, the integration of AI, and more.

February 10th 2025

FDA grants 510(k) clearance to AI-powered prostate cancer diagnostic

Hannah Clarke

The software generates heatmaps to help identify prostatic tumors that may have been missed on initial reads.